Researchers at Mount Sinai found long-term cocaine abuse linked to deficits in parts of the brain monitoring behavior, suggesting targeted treatments based on quantifiable biological abnormalities. The study's findings challenge clinical assumptions about addicted individuals' motivations and behaviors.
Researchers identified critical role of stem cell factor in cardiac repair and regeneration, showing potential clinical benefits of gene transfer to reverse heart damage. The study demonstrated significant improvement in cardiac function and reduced heart muscle cell death.
A multicenter clinical trial found similar patient outcomes one year after surgery for both mitral valve repair and replacement. However, mitral valve replacement was shown to be more durable than repair in preventing recurrence of mitral regurgitation.
A 3-year study in Colombia found that preschoolers participating in a structured curriculum using Sesame Street's materials improved their knowledge of healthy eating and exercise habits by 15-27%. The percentage of children at a healthy weight increased by 13%. Parents' knowledge and attitudes also showed significant improvements.
A single dose of AAV1/SERCA2a gene therapy has long-lasting benefits for advanced heart failure patients, improving heart function status and reducing recurrent cardiovascular events. The study results support the potential use of this gene therapy as a new tool for treating advanced heart failure.
Researchers found that patients with major HAIs after cardiac surgery were nearly twice as likely to be readmitted and incurred costs averaging $40,000 due to treating HAI infections.
A new study published at AHA Scientific Sessions 2013 found that a single dose of stem cell therapy during surgery may improve heart function in LVAD patients. Researchers discovered that 50% of patients who received the treatment could tolerate temporarily turning down their device, compared to 20% of placebo patients.
Arvin Dar, Ph.D., a structural and chemical biologist at Mount Sinai, is awarded $2.5 million to investigate new targets for interrupting the Ras pathway. The goal is to develop new classes of small molecule drugs that impede cancers.
A new gene therapy has shown promising results in reversing heart failure by delivering the SUMO-1 gene directly to the heart. In preclinical testing, the therapy improved cardiac function, reduced heart volumes, and enhanced blood flow compared to other treatments.
A significant link has been found between high levels of exposure to particulate matter by first responders at Ground Zero and the development of kidney damage. Albuminuria, a sign of kidney disease, was significantly higher in those with high exposure levels.
A pilot initiative at Mount Sinai Hospital shows that establishing standardized criteria for calling a palliative care consultation improves the quality of care for patients hospitalized with advanced cancer. This led to increased use of hospice services, lower in-hospital mortality and hospital readmission rates.
Mount Sinai researchers uncover the role of TGFβ2 in determining tumor cell behavior, revealing its potential as a biomarker for dormant cancer cells. The study confirms the 'seed and soil' theory of metastasis, suggesting that conditions within each organ influence tumor cell growth.
A study led by Dr. Pasinetti found that diabetes alters gene expression in the brain, reducing important molecules critical for learning and memory. This epigenetic change increases the risk of developing Alzheimer's disease.
A study by researchers from the Mount Sinai Hospital found that nearly 80% of women who contacted a patient assistance program had their needs met, compared to just 35% of those who did not. Most patients utilized programs for information about adjuvant therapies, psychosocial support, and overcoming practical/financial obstacles.
A team of researchers at Mount Sinai used systems biology and big data analysis to find that combining diabetes drug rosiglitazone with exanatide reduced heart attacks. The approach identifies potential safer combinations, sparking interest in repurposing FDA-approved drugs.
A study led by researchers at Mount Sinai found that individuals with autism were more likely to have gene deletions than those without the disorder, which may contribute to miswiring of brain neurons. The study suggests that these deletions could impact genetic testing and have clinical significance.
A collaborative study between Spain and the Icahn School of Medicine at Mount Sinai found that administering beta-blocker medication to heart attack patients while in transit can significantly reduce heart damage. The study showed metoprolol therapy resulted in smaller infarcts and improved heart contractility.
Researchers have discovered that mucus in the large intestine has anti-inflammatory properties, helping to prevent bacterial-induced inflammation. The study proposes that mucus could be used to treat various diseases, including IBD and cancer, and may even be manufactured for oral administration.
Researchers have discovered a network of genes in stem cells that foster cooperation, which is essential for the development and function of multicellular organisms. The study suggests that understanding this genetic mechanism could lead to new ways to address diseases such as cancer and immune system dysfunction.
Researchers developed a new system to test how viruses interact with cells in the body, revealing insights that will improve viral therapy. The technology allows for the use of real viruses in real environments, enabling scientists to study host targets for antiviral drugs.
Researchers aim to understand and address disparities in CRC screenings for African Americans, with a focus on developing effective intervention strategies. The study seeks to compare the effectiveness of narrative and didactic approaches to educating African Americans about screening.
Researchers at the Seaver Autism Center will test Insulin-Like Growth Factor-1 (IGF-1) in children with Phelan-McDermid Syndrome, a severe type of autism. IGF-1 has shown preclinical promise in reversing nerve cell communication deficits and restoring learning and memory abilities.
Researchers from The Mount Sinai Hospital have developed a new strategy to safely study deadly influenza viruses, including H5N1 bird flu. By harnessing the power of human lung cells, they create 'viral scissors' that can cut these viruses into pieces, preventing effective transmission to humans.
Researchers have developed a new laboratory model to study hepatitis C by infecting monkey stem cells with the virus. The model may lead to new treatments and vaccines for the disease, which affects over three million people in the US.
Researchers found that high dietary sugar acts together with oncogenes to increase insulin sensitivity specifically in tumor cells. A three-drug combination blocking sugar conversion, Ras/Src signaling, and Wingless/Wnt signaling substantially reduced tumor size and progression.
The Mount Sinai Hospital is launching the first-ever genetic testing program in primary care settings to identify genetic risk for kidney disease in patients with hypertension. This $3.7 million grant will provide genomic information to individualize treatment, testing, and monitoring, with a focus on African Americans who are four to ...
Researchers have shown that inhalable gene therapy can completely reverse pulmonary arterial hypertension in rat models and reduce expression of SERCA2a, an enzyme critical for calcium pumping. This approach may offer a promising therapeutic intervention for PAH patients.
A gene mutation disrupts immune cell activity, causing liver attacks in autoimmune hepatitis. Researchers create model to study treatment targets and therapies.
Researchers at Mount Sinai identified a critical protein called VP35 that deactivates the innate immune system, allowing Ebola viruses to spread. Overexpressing a cellular protein called PACT inhibited viral replication, providing a potential target for new treatments.
Dr. Valentin Fuster received the 2013 SCCT Arthur S. Agatston Cardiovascular Disease Prevention Award for his groundbreaking work on atherosclerosis development and prevention of coronary artery disease. The award honors Dr. Fuster's pioneering efforts in uncovering the molecular and cellular bases of atherosclerosis.
Researchers have identified a new chemical compound, CYM51010, that targets the opioid receptor complex and shows promise as an alternative to morphine. The compound is potent and less likely to result in tolerance and negative side effects.
Dr. Partho Sengupta presented the first-ever hologram presentation at the ASE's 2013 24th Annual Scientific Sessions, utilizing 3D digital images and expert interview recordings to analyze cardiovascular system structure, function, and flow patterns. This innovative presentation format was made possible through collaborative efforts of...
The Fondation Leducq has awarded a $6 million grant to a new global research network focused on cardiac regeneration. The network, which includes researchers from the Cardiovascular Research Center at Mount Sinai, aims to identify cellular and molecular targets for advancing cardiac regenerative therapeutics.
Researchers found that a single dose of Ritalin improved brain function in cocaine-addicted individuals, strengthening connections between regions involved in regulating emotions and behaviors. The study suggests potential as an add-on treatment for addiction to cocaine and other stimulants.
Mount Sinai researchers discover that diabetics using glucose meters at appointments have improved disease control. A study found that patients with controlled diabetes had a lower Hemoglobin A1c level compared to those without monitored glucose levels.
Researchers at Mount Sinai have made a breakthrough in programming blood-forming stem cells, which could lead to the development of patient-specific blood products. The study uses mouse fibroblast cells and identifies a combination of four genetic factors that can generate blood vessel precursor cells with hematopoietic cells.
Researchers at The Mount Sinai Medical Center found that commonly prescribed medications can either block or enhance beta-amyloid accumulation in the brain. Treatment with certain drugs has been shown to significantly reduce amyloid plaques and neurodegeneration in mice.
Researchers from the Seaver Autism Center at Mount Sinai identified common clinical symptoms of Phelan-McDermid Syndrome, including severe to profound intellectual disability, seizures, and low muscle tone. The study provides important guidance for developing a standardized assessment methodology for this disorder.
Researchers at Mount Sinai have discovered a novel liver progenitor cell that can be differentiated from human embryonic stem cells and produce mature liver cells. This breakthrough discovery has the potential to revolutionize the treatment of liver disease, potentially overcoming the organ shortage issue.
A pioneering study demonstrates the benefit of MRI in identifying mental illnesses such as bipolar disorder. The advanced imaging technique was able to correctly distinguish patients from healthy individuals with a high degree of accuracy, promising a new approach to diagnosis.
Mount Sinai researchers identified genetic markers for survival in melanoma patients and found high readmission rates after cancer surgery in non-teaching hospitals and among black patients. They also discovered low prevalence of spousal HPV infection, reassuring long-term partners that their risk is very low.
Two genetic mutations, PDGFRB and NOTCH3, have been identified as potential therapeutic targets for infantile myofibromatosis (IM), a rare and debilitating disorder. Current treatment options involve repeated surgical removal of tumors, which can be invasive and disfiguring.
Researchers found ketamine to be effective in treating treatment-resistant depression within 24 hours, with a response rate of 63.8% compared to 28% in the placebo group. The antidepressant benefits were durable after seven days, making ketamine a promising new treatment option for patients with severe and refractory forms of depression.
A study found that children living near toxic waste sites in lower and middle income countries have high blood lead levels, resulting in a loss of IQ points and higher incidence of mental retardation. The researchers estimated that 6 out of every 1,000 children could experience mild mental retardation.
A study by a Mount Sinai researcher found that toxic waste sites with high levels of lead and chromium cause a significant number of 'healthy years of life lost' among individuals living near the sites. The study calculated 828,722 lost years of full health due to disease, disability, or early death.
Researchers at Mount Sinai identified new targets for abnormal cell division, finding that blocking CDK7 can inhibit the activity of other critical enzymes CDK4 and CDK6. This discovery suggests turning off these enzymes may be an effective therapeutic target for preventing cancer cell proliferation.
Researchers identified a network of genes involved in inflammatory response driving Late Onset Alzheimer's Disease (LOAD), providing new understanding of key pathways and genes. The study suggests targeting the TREM2-TYROBP pathway as potential therapies for LOAD.
Researchers at Mount Sinai identify 14 genetic targets associated with heart rate, which could lead to new drugs for treating cardiovascular disease. The study's findings also shed light on the genetic regulation of heartbeats and cardiac conduction disorders.
Researchers at Mount Sinai have identified a soy-based compound, genistein, that can inhibit tumor cell growth and block Wnt signaling hyperactivity in colorectal cancer. Genistein has shown promise as an adjunctive treatment for metastatic colorectal cancer when used in combination with chemotherapy.
A recent review article highlights the need for preventive measures, genetic risk factors, and new diagnostic tools to identify the effects of traumatic brain injury (TBI) in athletes and soldiers. Researchers propose large-scale trials and genome-wide association studies to characterize CTE and develop prevention strategies.